Table 2. Clinical features of 65 esophageal squamous cell carcinoma patients with malignant tracheoesophageal/bronchoesophageal fistula receiving an esophageal metallic stent or a feeding gastrostomy/jejunostomy.
| Parameters | No. of patients | ||
| Esophageal metallicstent (n = 30) | Feeding gastrostomy/jejunostomy (n = 35) | P value | |
| Age (Mean ± SD): 50.29±9.52 | 51.20±11.08 | 49.51±8.04 | 0.49 |
| 7th AJCC stage | |||
| IIIc | 19 | 23 | 0.84 |
| IV | 11 | 12 | |
| Respiratory location of the fistula | |||
| Above carina | 15 | 20 | 0.57 |
| Below carina | 15 | 15 | |
| Primary location of the tumor | |||
| Upper | 5 | 8 | 0.53 |
| Middle/Lower | 25 | 27 | |
| Radiotherapy after fistula | |||
| Absent | 16 | 25 | 0.13 |
| Present | 14 | 10 | |
| Radiotherapy before fistula | |||
| Absent | 14 | 16 | 0.94 |
| Present | 16 | 19 | |
SD, standard deviation;
*
Statistically significant. X2 test, Fisher’s exact test or t test was used for statistical analysis.